Impact of Smoking on Long-Term Revascularization Success and Complications in Multivessel Percutaneous Coronary Intervention: A Retrospective Cohort Study

Authors

  • Tariq Shah Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Syed Muzammil Shah Department of Cardiology, Kuwait Teaching Hospital, Peshawar, Pakistan
  • Fahad Raja Khan Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan
  • Rafi Ullah Department of Cardiology, Kuwait Teaching Hospital, Peshawar, Pakistan
  • Muhammad Abdul Wahab Department of Cardiology, Federal Govt: Polyclinic Islamabad, Pakistan
  • Syed Kashif ur Rahman Department of Interventional Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v2i02.165

Keywords:

Smoking, Percutaneous Coronary Intervention, Multivessel Disease, Revascularization Success, Major Adverse Cardiac Events, Restenosis, Drug-Eluting Stents

Abstract

Background: Smoking is a major modifiable risk factor in coronary artery disease (CAD) and is associated with adverse outcomes following percutaneous coronary intervention (PCI). PCI, widely utilized for revascularization in multivessel CAD, aims to restore coronary blood flow and reduce ischemic complications. However, smokers face increased risks of restenosis and major adverse cardiac events (MACE) after PCI, highlighting a need for further investigation into these associations.

Objective: This study aimed to assess the impact of smoking on revascularization success and complications in patients undergoing multivessel PCI.

Methods: A retrospective cohort study was conducted at a tertiary cardiovascular center, evaluating clinical data from patients who underwent PCI from January 1, 2023, to December 31, 2023. Patients aged 18 and older with confirmed multivessel CAD were included. Participants were divided into smokers (N=779) and non-smokers (N=779) based on documented smoking status. All patients underwent PCI with either drug-eluting stents (DES) or drug-eluting balloons (DEB), followed by standard dual antiplatelet therapy. The primary outcome was revascularization success, defined as achieving TIMI grade ≥2. Secondary outcomes included incidences of MACE and restenosis. Statistical analyses were performed using SPSS v27, with t-tests and chi-square tests used for continuous and categorical variables, respectively. Logistic regression adjusted for confounders.

Results: Revascularization success was significantly lower in smokers (69.8%) compared to non-smokers (81.6%) (p < 0.001). Smokers also exhibited higher rates of MACE (15.5%) and restenosis (12.6%) versus 8.4% and 7.3% in non-smokers, respectively (p < 0.001 for both outcomes).

Conclusion: Smoking negatively affects revascularization success and increases MACE and restenosis risks in multivessel PCI patients. These findings underscore the importance of tailored therapeutic strategies and smoking cessation efforts to improve PCI outcomes in this high-risk group.

References

US Department of Health and Human Services. (2014). The health consequences of smoking—50 years of progress: a report of the Surgeon General.

Newby, D. E., Wright, R. O., Labinjoh, C., Ludlam, C. A., Fox, K. A. A., Boon, N. A., & Webb, D. J. (1999). Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking. Circulation, 99(11), 1411–1415. https://doi.org/10.1161/01.cir.99.11.1411

Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., Parise, H., Templin, B., White, R., Zhang, Z., & Serruys, P. W. (2011). A Prospective Natural-History Study of Coronary Atherosclerosis. New England Journal of Medicine, 364(3), 226–235. https://doi.org/10.1056/nejmoa1002358

Lordkipanidzé, M., Diodati, J. G., Schampaert, E., Palisaitis, D. A., & Pharand, C. (2009). Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease. The American Journal of Cardiology, 104(9), 1189–1193. https://doi.org/10.1016/j.amjcard.2009.06.025

Giustino, G., Mehran, R., Dangas, G. D. et al. (2017). Coronary revascularization in patients with diabetes mellitus. J Am Coll Cardiol, 70(8), 932-942. https://doi.org/10.1016/j.jacc.2017.07.763

Ishii, H., Shinoda, Y., Takahashi, H. et al., (2012). Impact of smoking on outcomes after drug-eluting stent implantation for coronary artery disease. Heart Vessels, 27(6), 548-554. https://doi.org/10.1007/s00380-011-0165-3

de Boer, S. P,, Lenzen, M. J., Oemrawsingh, R. M et al., (2009). Predictors of adverse events among patients undergoing PCI: Importance of smoking and diabetes. Heart, 95(22), 1995-2002. https://doi.org/10.1136/hrt.2008.155416

Brener, S. J, Lytle, B. W, Casserly, I. P. (2004). Smoking status and outcomes after coronary artery bypass graft surgery. Circulation. 2004;110(11 Suppl 1). https://doi.org/10.1161/01.CIR.0000138828.79291.91

Ben-Dor, I., Fuchs, S., Kornowski, R., et al., (2009). Smoking and clinical outcomes after percutaneous coronary intervention in acute coronary syndromes. Am J Cardiol, 104(9), 1179-1183. https://doi.org/10.1016/j.amjcard.2009.06.025

Ishii, H, Shinoda Y, Takahashi H, et al. Impact of smoking on outcomes after drug-eluting stent implantation for coronary artery disease. Heart Vessels. 2012;27(6):548-554. https://doi.org/10.1007/s00380-011-0165-3

Newby, D. E., Wright, R. O., Labinjoh, C., Ludlam, C. A., Keith A.A. Fox, Boon, N. A., & Webb, D. J. (1999). Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking. Circulation, 99(11), 1411–1415. https://doi.org/10.1161/01.cir.99.11.1411

Ambrose, J. A., & Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease. Journal of the American College of Cardiology, 43(10), 1731–1737. https://doi.org/10.1016/j.jacc.2003.12.047

Windecker, S., Kolh, P., Alfonso, F., et al., (2014). 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 35(37), 2541-2619. https://doi.org/10.1093/eurheartj/ehu278

Ockene, I. S., & Miller, N. H. (1997). Cigarette Smoking, Cardiovascular Disease, and Stroke. Circulation, 96(9), 3243–3247. https://doi.org/10.1161/01.cir.96.9.3243

Ben-Dor, I., Fuchs, S., Kornowski, R., et al., (2009). Smoking and clinical outcomes after percutaneous coronary intervention in acute coronary syndromes. Am J Cardiol. 104(9), 1179-1183. https://doi.org/10.1016/j.amjcard.2009.06.025

Brener, S., J., Lytle, B., W., Casserly, I. P. (2004).Smoking status and outcomes after coronary artery bypass graft surgery. Circulation, 110(11 Suppl 1). https://doi.org/10.1161/01.CIR.0000138828.79291.91

Nakamura, K., Barzi, F., Lam, T., H. et al., (2008). Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific Region. Stroke. 39(6), 1694-1702. https://doi.org/10.1161/STROKEAHA.107.495127

Møller, C. H., Penninga, L., Wetterslev, J., Steinbrüchel, D. A., & Gluud, C. (2012). Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd007224.pub2

Fröhlich, M., Sund, M., Löwel, H., et al., (2003). Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 24(14), 1365-1372. https://doi.org/10.1016/S0195-668X(03)00260-8

Ishii, H., Shinoda, Y., Takahashi, H. et al., (2012). Impact of smoking on outcomes after drug-eluting stent implantation for coronary artery disease. Heart Vessels. 27(6), 548-554. https://doi.org/10.1007/s00380-011-0165-3

Tverdal, A., Skurtveit, S., Meyer, H, E. (2003). Smoking cessation and risk of myocardial infarction: A nationwide cohort study. Eur J Epidemiol. 18(12), 1089-1095. https://doi.org/10.1023/B.0000006610.40196.45

Mikkelsen, K, L, Nielsen, C, Tønnesen, H, et al. (2008). Smoking delays vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) receptor signaling and decreases tissue perfusion in wound healing. Surgery, 144(2), 243-252. https://doi.org/10.1016/j.surg.2008.03.021

Theodoro, T., R., Benatti, F., B., Okuda, L. S. et al. (2016). Smoking and clinical outcomes after percutaneous coronary intervention in patients with acute coronary syndrome: a retrospective cohort study. Clin Cardiol, 39(8), 469-476. https://doi.org/10.1002/clc.22554

Rigotti, N. A. (2011). Smoking cessation in patients with cardiovascular disease: What works? Cardiol Clin, 29(1), 83-97. https://doi.org/10.1016/j.ccl.2010.10.003

Lippi, G., Favaloro, E, J, Franchini, M. (2010). Smoking and cardiovascular risk: A critical appraisal of epidemiologic evidence. Clin Chim Acta. 411(11-12), 769-774. https://doi.org/10.1016/j.cca.2010.02.048

Downloads

Published

2024-11-04

How to Cite

Shah, T., Shah, S. M., Khan, F. R., Rafi Ullah, Muhammad, A. W., & Syed, K. ur R. (2024). Impact of Smoking on Long-Term Revascularization Success and Complications in Multivessel Percutaneous Coronary Intervention: A Retrospective Cohort Study. Indus Journal of Bioscience Research, 2(02), 223–230. https://doi.org/10.70749/ijbr.v2i02.165